» Authors » Daniel Menezes-Souza

Daniel Menezes-Souza

Explore the profile of Daniel Menezes-Souza including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 79
Citations 646
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Freire L, Costa S, Tedeschi A, Santos L, Ribeiro N, Cruz L, et al.
Exp Parasitol . 2025 Feb; 270:108914. PMID: 39921056
In the present study, we investigated the potential use of five linear peptides as a potential antigens for the immunodiagnosis of tegumentary leishmaniasis (TL) and canine visceral leishmaniasis (CVL). We...
2.
Medeiros F, Souza Filho J, Pimentel M, Reis I, Menezes-Souza D, Silva A, et al.
Rev Inst Med Trop Sao Paulo . 2024 Dec; 66:e70. PMID: 39699426
Diagnostic networks ensure efficiency in disease diagnosis. A descriptive study evaluated the network of public health laboratories (NPHL) in Minas Gerais State, Brazil, using diagnostic results for tegumentary leishmaniasis (TL)...
3.
Moura D, Carvalho A, Brito R, Roatt B, Pagliara Lage D, Martins V, et al.
Vaccine . 2024 Aug; 42(21):126178. PMID: 39096765
American Tegumentary Leishmaniasis (ATL) is a disease of high severity and incidence in Brazil, in addition to being a worldwide concern in public health. Leishmania amazonensis is one of the...
4.
Ribeiro N, Santos L, Costa S, Kei Myasaki C, Pagliara Lage D, Martins V, et al.
Eur J Pharm Biopharm . 2024 Apr; 199:114306. PMID: 38679213
In the context of neglected diseases, tegumentary leishmaniasis (TL) presents an emerging and re-emerging character in the national territory and in the world. The treatment of TL has limitations, such...
5.
Jesus M, Lage D, Vale D, Freitas C, Pimenta B, Moreira G, et al.
Parasitol Res . 2023 Sep; 122(12):2917-2931. PMID: 37768367
Tegumentary leishmaniasis (TL) is the main clinical manifestation of leishmaniasis, and it can cause the infected hosts to self-healing cutaneous lesions until mutilating scars in mucosal membranes, particularly in the...
6.
Vercosa B, Muniz-Junqueira M, Menezes-Souza D, Fujiwara R, Borges L, Melo M, et al.
Mol Immunol . 2023 Mar; 156:61-76. PMID: 36889187
Collagen deposition is a common event in chronic inflammation, and canine Leishmaniosis (CanL) is generally associated with a long and chronic evolution. Considering that the kidney shows fibrinogenic changes during...
7.
Soyer T, Ramos F, Pereira I, Lage D, Bandeira R, de Jesus M, et al.
Pathogens . 2023 Feb; 12(2). PMID: 36839586
can cause cutaneous and visceral clinical manifestations of leishmaniasis in infected hosts. Once the treatment against disease is toxic, presents high cost, and/or there is the emergence of parasite-resistant strains,...
8.
Costa S, Santos L, Freire L, Tedeschi A, Ribeiro N, Queiroz M, et al.
Acta Trop . 2023 Feb; 241:106865. PMID: 36787861
In the present study, an immunoproteomic approach using Leishmania infantum parasites isolated from naturally infected dogs from an endemic region of the disease, was carried out to identify new antigens...
9.
Lage D, Machado A, Freitas C, Vale D, Linhares F, Cardoso J, et al.
Mol Immunol . 2023 Feb; 155:79-90. PMID: 36731193
Vaccination against visceral leishmaniasis (VL) should be considered as a safe and effective measure to disease control; however, few vaccines are available against canine VL and there is no an...
10.
Carvalho A, Ferraz I, Hojo-Souza N, Medeiros F, Viana L, Bartholomeu D, et al.
Acta Trop . 2022 Nov; 237:106749. PMID: 36370753
The pathogenesis of Chronic Chagas Cardiomyopathy (CCC) is still not fully understood, and the persistence of the parasite in tissues seems to be essential for the onset and progression of...